City of Hope
1500 E Duarte Rd
About City of Hope
City of Hope is a leading research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope's main hospital is located in Duarte, Calif., just northeast of Los Angeles, with clinics throughout southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S.News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics.
Individually we are many things. Together, we are hope.
6 articles with City of Hope
Real Estate Industry Luminary Yat-Pang Au of Veritas Investments To Be Honored with City of Hope’s Prestigious Spirit of Life® Award at Dinner Gala on Sept. 26
City of Hope’s Northern California Real Estate Council will honor Yat-Pang Au, chief executive officer of Veritas Investments, with its 2018 Spirit of Life® Award at its annual gala on Sept. 26, 2018, at the Fairmont Hotel.
Albertsons, Vons and Pavilions Stores Raise Over $1 Million for City of Hope’s Research and Treatment for Childhood Cancers
City of Hope’s annual Kids 4 Hope program, in partnership with Albertsons Companies Foundation, Vons Foundation and Pavilions Foundation, has raised over $1 million to support research and treatment for pediatric cancers.
Family of Beverly and Ben Horowitz Creates Fund at City of Hope to Advance Innovative CAR T Cell Therapy Research
In memory of Ben and Beverly Horowitz, longtime chief executive officer and first lady of City of Hope, their family has donated $1 million to City of Hope to help advance groundbreaking CAR T cell immunotherapy research to combat cancer.
City of Hope Appoints Jennifer Parkhurst as Chief Financial Officer and Mark Hulse as Chief Digital Officer
Both are members of City of Hope’s Enterprise Leadership Team and report directly to the institution’s President and Chief Executive Officer Robert W. Stone.
City of Hope Physicians Report on New CAR-T Cell Therapy for Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm at American Society of Hematology Annual Meeting
City of Hope patients whose acute myeloid leukemia (AML) was no longer responding to standard therapies and a patient with a rare blood cancer, blastic plasmacytoid dendritic cell neoplasm, achieved a complete response (cancer-free) after undergoing treatment with MB-102 CAR-T therapy, which targets CD123 cells.
City of Hope Physicians Present New CAR-T Cell Therapy Study Results and Other Research at 2017 American Society of Hematology Annual Meeting
The trials, presented by City of Hope physicians and researchers, could ultimately lead to innovative therapeutic approaches that improve treatment options and quality of life for patients with blood cancers and other diseases.